PRESS RELEASE published on 11/28/2024 at 18:40, 1 year 4 months ago Informations privilégiées / Autres communiqués Medincell tiendra une vidéoconférence pour présenter ses résultats financiers semestriels le mardi 10 décembre 2024. La société développe des médicaments injectables à action prolongée dans divers domaines thérapeutiques Résultats Financiers Medincell Médicaments Injectables Videoconference Technologie BEPO
BRIEF published on 11/22/2024 at 18:05, 1 year 4 months ago MedinCell : Mise à jour du capital social et des droits de vote Droits De Vote Euronext Capital Social Actions Medincell
BRIEF published on 11/22/2024 at 18:05, 1 year 4 months ago MedinCell: Update of share capital and voting rights Share Capital Voting Rights Euronext Actions Medincell
PRESS RELEASE published on 11/22/2024 at 18:00, 1 year 4 months ago Informations privilégiées / Autres communiqués Euronext informe sur les droits de vote et le capital social de MedinCell. MedinCell, biopharmaceutique en France, développe des médicaments injectables à action prolongée Droits De Vote Euronext Capital Social Biopharmaceutique Medincell
BRIEF published on 11/06/2024 at 13:47, 1 year 4 months ago Medincell : Revenus 2024 à la hausse et avancée clinique significative Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
BRIEF published on 11/06/2024 at 13:47, 1 year 4 months ago Medincell: 2024 revenues on the rise and significant clinical progress Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
PRESS RELEASE published on 11/06/2024 at 13:42, 1 year 4 months ago Informations privilégiées / Autres communiqués Medincell relève ses prévisions de revenus UZEDY® de 25% et franchit une étape majeure dans l'essai clinique de l'Olanzapine LAI. Tous les détails dans le communiqué de presse de Teva pour le troisième trimestre 2024 Revenus Essai Clinique Medincell Teva UZEDY
PRESS RELEASE published on 11/06/2024 at 13:42, 1 year 4 months ago Inside Information / Other news releases Medincell achieves 25% increase in 2024 UZEDY® revenue outlook reaching $100M and key milestone in Olanzapine LAI Phase 3 clinical trials. Teva Pharmaceuticals shares Q3 results Revenue Clinical Trials Medincell Teva Pharmaceuticals UZEDY
BRIEF published on 10/01/2024 at 15:47, 1 year 5 months ago Franchissement de seuil par Mirova dans MEDINCELL Capital Franchissement De Seuil Actions Medincell Mirova
BRIEF published on 10/01/2024 at 15:47, 1 year 5 months ago Threshold crossing by Mirova in MEDINCELL Capital Actions Threshold Crossing Medincell Mirova
Published on 04/01/2026 at 15:00, 16 minutes ago Karbon-X Named Official Sustainability Partner of the Detroit Red Wings and Detroit Tigers
Published on 04/01/2026 at 14:30, 46 minutes ago Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
Published on 04/01/2026 at 14:00, 1 hour 16 minutes ago Dateline Completes A$50M Institutional Placement to Advance Colosseum
Published on 04/01/2026 at 14:00, 1 hour 16 minutes ago Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago
Published on 04/01/2026 at 13:30, 1 hour 46 minutes ago Electric Metals (USA) Limited Announces OTCQB Ticker Symbol Change to EMUS and Grants Deferred Share Units to Directors
Published on 04/01/2026 at 15:08, 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 04/01/2026 at 15:07, 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 04/01/2026 at 15:06, 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 04/01/2026 at 08:00, 7 hours 16 minutes ago Transfert du contrat de liquidité aupres de Natixis Oddo BHF
Published on 04/01/2026 at 08:00, 7 hours 16 minutes ago Résultats annuels 2025 - ANR par action en hausse de + 8,1 % à 97,10 € - Fonds propres consolidés : 740 M€
Published on 03/31/2026 at 20:08, 19 hours 8 minutes ago SMTPC - Communiqué sur les résultats annuels 2025
Published on 03/31/2026 at 19:05, 20 hours 11 minutes ago SFPI GROUP: implementation of a new liquidity contract
Published on 03/31/2026 at 19:05, 20 hours 11 minutes ago Groupe SFPI : mise en oeuvre d'un nouveau contrat de liquidité
